Pei-Ru Wey’s primary focus is on patent prosecution and intellectual property (IP) litigation. In patent prosecution, Pei-Ru works closely with inventor-scientists to understand and realize the full potential of their inventions. Her experience spans medical, diagnostic, pharmaceutical, nutraceutical, chemical and consumer product technologies.
Pei-Ru is also an experienced IP litigator, with a focus on Hatch-Waxman litigation. As a pharmacist-attorney, Pei-Ru combines her scientific knowledge and patient counseling experience to break down complex technology and IP legal concepts to target audiences.
Pei-Ru’s practice further includes patentability, freedom-to-operate, invalidity and noninfringement opinions across a range of technologies.
- Helped inventors secure biologic patent rights by overcoming 101 rejections.
- Assisted generic drug manufacturers in trial and/or settlement prior to trial in numerous Hatch-Waxman litigations.
- Successfully defend a generic drug manufacturer in a patent infringement suit with an award of 1.9 million in attorney fees.
- Helped a consumer product company enforce its patent against a competitor by quickly reaching settlement on favorable terms.
Pei-Ru is conversant in Mandarin Chinese.
Co-Author: Touhey Myer
District Courts respond in various ways to the increase in pretrial motions based on Section 101, patent eligibility. Here is a look at the practices of some of the districts with the most active patent dockets…